A new frontier for TAVR: Aortic insufficiency in CF-LVAD patients.

[1]  V. Rajagopal,et al.  Short-term results with transcatheter aortic valve replacement for treatment of left ventricular assist device patients with symptomatic aortic insufficiency. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  C. Datz,et al.  Transcatheter aortic valve replacement for pure aortic valve regurgitation: “on-label” versus “off-label” use of TAVR devices , 2019, Clinical Research in Cardiology.

[3]  Koji Takeda,et al.  Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry. , 2018, JACC. Heart failure.

[4]  Weiqi Wang,et al.  Transapical transcatheter aortic valve replacement for aortic regurgitation with a second‐generation heart valve , 2018, The Journal of thoracic and cardiovascular surgery.

[5]  L. Conradi,et al.  First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  Jeroen J. Bax,et al.  Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. , 2017, Journal of the American College of Cardiology.

[7]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[8]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[9]  M. Deutsch,et al.  Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. , 2017, JACC. Cardiovascular interventions.

[10]  S. Kapadia,et al.  Percutaneous Transcatheter Interventions for Aortic Insufficiency in Continuous-Flow Left Ventricular Assist Device Patients: A Systematic Review and Meta-Analysis , 2017, ASAIO journal.

[11]  V. Jeevanandam,et al.  Predictors of survival following trans‐catheter aortic valve closure for left ventricular assist device associated aortic insufficiency , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  Karen May-Newman,et al.  Comprehensive review and suggested strategies for the detection and management of aortic insufficiency in patients with a continuous-flow left ventricular assist device. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  M. Pasic,et al.  Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. , 2014, JAMA.

[14]  Susheel Kodali,et al.  Prevalence, Significance, and Management of Aortic Insufficiency in Continuous Flow Left Ventricular Assist Device Recipients , 2014, Circulation. Heart failure.

[15]  J. Rogers,et al.  Surgical correction of aortic valve insufficiency after left ventricular assist device implantation. , 2013, The Journal of thoracic and cardiovascular surgery.

[16]  Nader Moazami,et al.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  Nir Uriel,et al.  Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  P. Eckman,et al.  Aortic insufficiency in continuous-flow left ventricular assist device support patients is common but does not impact long-term mortality. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.